Is SVR4 Testing an Acceptable Alternative Measure of HCV Cure in Re-Treated Patients Following DAA Failure? A SVR4/12 Concordance Evaluation from the POLARIS Clinical Trials
Marc Bourliere, MD, Presenter
Hepatitis
9:58 AM - 10:03 AM
Nov
09
2025
Washington, D.C.
National population-based hepatitis C screening and elimination programme in Lithuania: what results have we achieved?